Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 23 hours ago

Indications

Apixaban is a factor Xa inhibitor. It is used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is also used for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. And it is used for the treatment of DVT and PE, and to reduce the risk of recurrent DVT and PE after initial therapy.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Apixaban works by inhibiting coagulation, so it stops blood clots from forming. Because it inhibits FXa, apixaban also lengthens clotting tests such as prothrombin time (PT), INR and activated partial thromboplastin time (aPTT). At the expected therapeutic dose, though, the changes seen in these tests are small and vary a great deal from one person to another. So they are not useful for monitoring the anticoagulation effect of apixaban.

Pregnancy & Breastfeeding

Pregnancy: There are no adequate and well-controlled studies of Apixaban in pregnant women. Treatment is likely to increase the risk of hemorrhage during pregnancy and delivery. Apixaban should be used in pregnancy only if the potential benefit outweighs the potential risk to the mother and the fetus.

Labor and Delivery: The safety and effectiveness of Apixaban during labor and delivery have not been studied in clinical trials. Think about the risk of bleeding and the risk of stroke when using Apixaban in this situation.

Nursing Mothers: It is unknown whether Apixaban or its metabolites pass into human milk. Women should be told either to stop breastfeeding or to stop Apixaban therapy, taking into account how important the medicine is to the mother.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Recommended Dose Most patients take Apixaban 5 mg orally, twice daily. Dosage Adjustments The dose of Apixaban is 2.5 mg twice daily for patients who have any 2 of these characteristics: age 80 years or above, body weight 60 kg or less, serum creatinine 1.5 mg/dl or above. CYP3A4 and P-gp inhibitors When Apixaban is given together with drugs that are strong dual inhibitors of cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp), for example ketoconazole, itraconazole, ritonavir and clarithromycin, the recommended dose is 2.5 mg twice daily. Missed Dose If a dose of Apixaban isn't taken at the scheduled time, it should be taken as soon as possible on the same day, and then twice-daily dosing should be resumed. The dose should not be doubled to make up for a missed one. Discontinuation for Surgery and Other Interventions Apixaban should be discontinued at least 48 hours before elective surgery or invasive procedures that carry a moderate or high risk of unacceptable or clinically significant bleeding. For elective surgery or invasive procedures with a low risk of bleeding, or where the bleeding would be non-critical in location and easily controlled, it should be discontinued at least 24 hours before. Switching from or to Apixaban Switching from warfarin to Apixaban Warfarin should be discontinued, and Apixaban started once the international normalized ratio (INR) is below 2.0. Switching from Apixaban to warfarin Apixaban affects INR, so INR measurements while the two are given together may not be useful for working out the right dose of warfarin. If continuous anticoagulation is necessary, discontinue Apixaban and begin both a parenteral anticoagulant and warfarin at the time the next dose of Apixaban would have been taken. The parenteral anticoagulant is then discontinued when the INR reaches an acceptable range. Switching between Apixaban and anticoagulants other than warfarin Discontinue the one being taken and begin the other at the next scheduled dose.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.

Key Interactions

Checker →